Oncology & Specialty

Specialty and oncology medications.

1,171 NDCs in catalog

Imatinib Mesylate

100 mg/1 · Film-Coated Tablet

NDC 60687-0882-21

30 BLISTER PACK in 1 CARTON (60687-882-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Imatinib Mesylate

100 mg/1 · Film-Coated Tablet

Available to Source

Imatinib Mesylate

400 mg/1 · Film-Coated Tablet

Available to Source

Itovebi (Inavolisib)

9 mg/1 · Film-Coated Tablet

Available to Source

Itovebi (Inavolisib)

3 mg/1 · Film-Coated Tablet

Available to Source

Lapatinib

250 mg/1 · Tablet

NDC 68180-0801-36

150 TABLET in 1 BOTTLE

Available to Source

Tykerb (Lapatinib)

250 mg/1 · Tablet

NDC 00078-0671-19

150 TABLET in 1 BOTTLE

Available to Source

Lapatinib

250 mg/1 · Film-Coated Tablet

NDC 42291-0035-15

150 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Lapatinib

250 mg/1 · Film-Coated Tablet

NDC 00480-3237-51

150 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Vitrakvi (Larotrectinib)

25 mg/1 · Capsule

NDC 50419-0390-01

60 CAPSULE in 1 BOTTLE

Available to Source

Vitrakvi (Larotrectinib)

20 mg/mL · Solution Concentrate

NDC 50419-0392-01

100 mL in 1 BOTTLE

Available to Source

Vitrakvi (Larotrectinib)

100 mg/1 · Capsule

NDC 50419-0391-01

60 CAPSULE in 1 BOTTLE

Available to Source

Vitrakvi (Larotrectinib)

20 mg/mL · Solution Concentrate

NDC 50419-0393-03

2 BOTTLE in 1 CARTON (50419-393-03) / 50 mL in 1 BOTTLE

Available to Source

Lazcluze (Lazertinib)

80 mg/1 · Film-Coated Tablet

NDC 57894-0080-60

1 BOTTLE in 1 CARTON (57894-080-60) / 60 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Lazcluze (Lazertinib)

80 mg/1 · Film-Coated Tablet

NDC 57894-0080-90

1 BOTTLE in 1 CARTON (57894-080-90) / 90 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Lazcluze (Lazertinib)

240 mg/1 · Film-Coated Tablet

NDC 57894-0240-30

1 BOTTLE in 1 CARTON (57894-240-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Available to Source

Lazcluze (Lazertinib)

240 mg/1 · Film-Coated Tablet

NDC 57894-0240-99

1 DOSE PACK in 1 CARTON (57894-240-99) / 14 TABLET, FILM COATED in 1 DOSE PACK

Available to Source

Harvoni (Ledipasvir and Sofosbuvir)

45 mg/1 / 200 mg/1 · Film-Coated Tablet

Available to Source

Harvoni (Ledipasvir and Sofosbuvir)

33.75 mg/1 / 150 mg/1 · Pellet

Available to Source

Harvoni (Ledipasvir and Sofosbuvir)

45 mg/1 / 200 mg/1 · Pellet

Available to Source

Ledipasvir and Sofosbuvir

90 mg/1 / 400 mg/1 · Film-Coated Tablet

NDC 72626-2601-01

2 BLISTER PACK in 1 CARTON (72626-2601-1) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Harvoni (Ledipasvir and Sofosbuvir)

90 mg/1 / 400 mg/1 · Film-Coated Tablet

Available to Source

Sunlenca (Lenacapavir Sodium)

300 mg/1 · Film-Coated Tablet

NDC 61958-3001-01

1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source

Sunlenca (Lenacapavir Sodium)

300 mg/1 · Film-Coated Tablet

NDC 61958-3001-02

1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK

Available to Source